Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome

World Journal of Urology

Volumn 32, Issue 1, 2014, Pages 179-184

  Souto, Sophia C ^a   Reis, Leonardo O ^a,b   Palma, Thais ^a   Palma, Paulo ^a   Denardi, Fernandes ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

Author keywords

Anticholinergics; Multimodal treatment; Non drug active therapies; Overactive bladder; Posterior tibial nerve stimulation (PTNS); Transcutaneous electrical neural stimulation (TENS)

Indexed keywords

MANDELIC ACID DERIVATIVE; OXYBUTYNIN; URINARY TRACT AGENT;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROSTIMULATION THERAPY; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TIBIAL NERVE; TREATMENT OUTCOME;

ADULT; AGED; COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MANDELIC ACIDS; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TIBIAL NERVE; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; UROLOGICAL AGENTS;

EID: 84893154129     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1112-5     Document Type: Article

References (14)

1. Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21: 167-178.
2. Abrams P, Cardozo L, Wein A (2012) 3rd international consultation on incontinence-research society 2011. Neurourol Urodyn 31: 291-292.
3. Bellette PO, Rodrigues Palma PC, Hermann V et al (2009) Posterior tibial nerve stimulation in the management of overactive bladder: a prospective and controlled study. Actas Urol Esp 33: 58-63.
4. Mattiasson A, Blaakaer J, Hoye K et al (2003) Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int 91: 154-160.
5. Burton C, Sajja A, Latthe PM (2012) Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn 31: 1206-1216.
6. Rai BP, Cody JD, Alhasso A et al (2012) Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev 12: CD003193.
7. Pelletier EM, Vats V, Clemens Q (2009) Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder. Am J Manag Care 15: S108-S114.
8. Anderson KE (2004) Antimuscarinics for treatment of overactive bladder. Lancet Neurol 3: 46-53.
9. Govier FE, Litwiller S, Nitti V et al (2001) Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 165: 1193-1198.
10. Peters KM, MacDiarmid SA, Wooldridge LS et al (2009) Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 182: 1055-1061.
11. Tellenbach M, Schneider M, Mordasini L et al (2012) Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome? World J Urol. doi: 10. 1007/s00345-012-0888-z.
12. Goode PS, Burgio KL, Locher JL et al (2002) Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. J Am Geriatr Soc 50: 808-816.
13. MacDiarmid SA, Peters KM, Shobeiri SA et al (2010) Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol 183: 234-240.
14. Levin PJ, Wu JM, Kawasaki A et al (2012) The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review. Int Urogynecol J 23: 1591-1597.